- ►shouxi.net T Kino, MU De Martino, E Charmandari, T … - Diabetes, 2005 - Am Diabetes Assoc HIV-1 accessory protein Vpr arrests host cells at the G2/M phase of the cell
cycle by interacting with members of the protein family 14-3-3, which regulate
the activities of “partner” molecules by binding to their ... Cited by 1 - Related articles - All 3 versions
B Maher, J Lloyd, EGL Wilkins, WD Fraser, D … - Antiviral therapy, 2004 - intmedpress.com Objective: To evaluate the effects of stopping treatment with protease
inhibitors (PIs) on tumour necrosis factor (TNF)-α and TNF-receptor levels, and
on the metabolic and morphological abnormalities seen in patients with ... Cited by 6 - Related articles - View as HTML - All 6 versions
T Kino, GP Chrousos - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2004 - interscience.wiley.com Abstract: Recent advances in the development of three different types of
antiviral drugs, the nucleotide and non-nucleotide analogues acting as reverse
transcriptase inhibitors (NRTIs) and the nonpeptidic viral protease ... Cited by 15 - Related articles - BL Direct - All 4 versions
P Limone, A Biglino, M Valle, M Degioanni, M … - Journal of Infection, 2003 - Elsevier Results. Plasma glucose levels did not differ in HIV patients and in controls.
Insulin concentrations and HOMA-IR were significantly higher in HIV-infected
patients than in controls (respectively, 11.4±4.3 vs. 7.86±1.1 mIU, ... Cited by 9 - Related articles - All 3 versions
[CITATION] Human Immunodeficiency Virus T^ pe-l Accessory Protein Vpr
T KINO, GP CHROUSOS - Glucocorticoid action: basic and clinical implications, 2004 - New York Academy of Sciences Related articles
S Bhasin, AB Singh, M Javanbakht - Endocrinology and metabolism clinics of North America, 2001 - Elsevier Functional derangement of every endocrine organ system has been reported in
association with HIV infection. The changes in endocrine function may be related
to the viral infection of the gland, to systemic effects of HIV or an ... Cited by 9 - Related articles - BL Direct - All 9 versions
NM Press, JSG Montaner, G Bondy - Endocrine Practice, 2004 - AACE New-onset diabetes mellitus, clinically similar to type 2 diabetes, will affect
a small proportion (1 to 6%) of human immunodeficiency virus (HIV)-infected
patients treated with protease inhibitor (PI)-based antiretroviral ... Cited by 2 - Related articles - BL Direct - All 2 versions
EM Evans, F Nye, NJ Beeching, GV Gill - Diabetic medicine, 2005 - ingentaconnect.com A 30-year-old African female with established acquired immunodeficiency syndrome
(AIDS) and no history of diabetes, presented in severe diabetic ketoacidosis
(DKA). Blood pH was 6.96, serum bicarbonate 5 mmol/l, plasma glucose (PG) ... Cited by 1 - Related articles - All 4 versions
J Koeppe, L Kosmiski - Clinical Infectious Diseases, 2006 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 1 - Related articles - All 3 versions
T Kino, M Tsukamoto, GP Chrousos - Biochemical and Biophysical Research …, 2002 - Elsevier The human immunodeficiency virus type-1 (HIV-1)-accessory protein Vpr interacts
with and potentiates the activity of the glucocorticoid receptor (GR) and
arrests the host cell cycle at the G2/M boundary. Here we report that three ... Cited by 3 - Related articles - BL Direct - All 4 versions
